Physician profile
Leah Walsh
NPI 1922643386
$1,073.25
in general payments reported to CMS, 2019-2025
12 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $520 · 2023: $189 · 2024: $182 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.85 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $183.86 | 2022-2025 | |
| Glaxosmithkline, LLC. | $124.84 | 2022-2025 | Benlysta |
| Amgen INC. | $119.43 | 2022-2025 | Tavneos, Evenity, Enbrel |
| Janssen Biotech, INC. | $115.03 | 2022-2025 | Tremfya |
| Alexion Pharmaceuticals, INC. | $57.63 | 2022 | |
| Ucb, INC. | $45.17 | 2023-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $31.65 | 2025 | Saphnelo |
| Pfizer INC. | $18.55 | 2024 | |
| Radius Health, INC. | $16.09 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $13.80 | 2024 | Arcalyst |
| Evolution Surgical, INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.